[1] 杨美剑.妇女保健与优生优育研究进展[J].实用妇科内分泌杂志(电子版),2017,4(4):10-11. [2] 中华人民共和国卫生部.中国出生缺陷防治报告 (2012)[R].北京:中华人民共和国卫生部,2012. [3] 胡淑怡,杜莉,朱丽萍.国内外围孕期保健服务研究进展[J].中国妇幼保健,2019,34(1):220-222. [4] World Health Organization. Congenital anomalies[R].Geneva: World Health Organization,2016. [5] Baldacci S,Gorini F,Santoro M,et al.Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiologicalevidence[J].Epidemiol Prev,2018,42(3-4Suppl1):1-34. [6] Almli LM. Association between infant mortality attributable to birth defects and payment source for delivery-United States,2011-2013[J].MMWR Morb Mortal Wkly Rep,2017,66(3):84. [7] Lamichhane DK,Leem JH,Park M,et al.Increased prevalence of some birth defects in Korea,2009-2010[J].BMC Pregnancy Childbirth,2016,16(1):1-10. [8] World Health Organization.Birth defect[R].Geneva:World Health Organization,2019. [9] Kurdi A,Majeed-Saidan M. World birth defects day. Towards a national registry for birth defects in Saudi Arabia[J].Saudi Med J,2015,36(2):143-145. [10] 刘永红,陈远明.我国干预新生儿出生缺陷工程的现状与进展[J].大众科技,2018,20(9):58-59. [11] 孙冰洁.我国22种出生缺陷大幅下降:更多重大出生缺陷病种有望纳入大病专项救治[EB/OL].[2019-07-26].http://guoqing.china.com.cn/2019-07/26/content_75036256.htm [12] CDC.Announcement: national birth defects prevention month and folic acid awareness week-January 2018[J].MMWRMorb Mortal Wkly Rep,2018,66(51-52):1411. [13] Grant GB,Desai S,Dumolard L,et al.Progress toward rubella and congenital rubella syndrome control and elimination-worldwide,2000-2018[J].MMWR Morb Mortal Wkly Rep,2019,68(39):855-859. [14] Kinsner-Ovaskainen A,Lanzoni M,Garne EE,et al.A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases Registration[J].Eur J Med Genet,2018,61(9):513-517. [15] Tucker FD,Morris JK,Neville A,et al.Correction to: EUROCAT: an update on its functions and activities[J].J Community Genet,2019,10(2):407-410. [16] Yoon PW.The national birth defects prevention study[J].Public Health Rep,2001,116(90001):32-40. [17] Tinker SC,Carmichael SL,Marlene A,et al.Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS)[M].Birth Defects Res A Clin Mol Teratol,2015. [18] Nitta H. Outline of the Japan environment and children's study andthe framework ofgenome analysis[J].Nihon Eiseigaku Zasshi,2016,71(1):91-93. [19] Mezawa H,Tomotaki A,Yamamoto-Hanada K,et al.Prevalence of congenital anomalies in the Japan environment and children's study[J].J Epidemiol,2019,29(7):247-256. [20] Johnson KJ,Lee JM,Ahsan K,et al.Pediatric cancer risk in association with birth defects:A systematic review[J].PLoS One,2017,12(7):e0181246. [21] Zaidi S,Brueckner M.Genetics and genomics of congenital heart disease[J].Circ Res,2017,120(6):923-940. [22] Thomford NE,Dzobo K,Yao NA,et al.Genomics and epigenomics of congenital heart defects: expert review and lessons learned in Africa[J].OMICS,2018,22(5):301-321. [23] 国家卫生健康委员会.中国妇幼健康事业发展报告(2019)[R].北京:国家卫生健康委员会,2019. [24] 程文.孕前健康体检的现状分析及孕前保健的模式研究[J].中国医药指南,2017,15(12):179-180. [25] 刘帅妹,张瑞金,周青,等.精准医学与出生缺陷预防[J].实用预防医学,2019,26(2):132-135. [26] 谢艳冰.分析产前胎儿系统超声筛查在减少出生缺陷中的临床应用[J].世界最新医学信息文摘,2019,19(74):201-202. [27] 余宏盛,胡晞江.基于高通量测序技术应用于孕期无创产前筛查人群的结果分析[J].实用医学杂志,2019,35(3):433-436. [28] 吴玥丽,张琳琳,李琳,等.高通量测序技术在无创性产前胎儿染色体缺失重复检测中的应用[J].中国计划生育学杂志,2019,27(6):789-792. [29] 陈欢,吴畏.胚胎植入前遗传学检测技术的发展及临床应用[J].国际生殖健康/计划生育杂志,2019,38(4):300-304. [30] 封纪珍,贾立云,王熙,等.石家庄地区128399例新生儿多种遗传代谢病串联质谱筛查结果分析[J].临床检验杂志,2020,38(5):344-349. [31] 白文学,龙川江.江津区新生儿串联质谱法遗传代谢病筛查研究[J].数理医药学杂志,2019,32(8):1180-1182. [32] 张亚果,苏星月,李婷,等.四川省部分地区新生儿遗传代谢病串联质谱筛查情况分析[J].中国儿童保健杂志,2020,28(7):809-812. [33] 郭克建,周旋,陈西贵,等.济宁地区48297例新生儿串联质谱法遗传代谢疾病筛查的应用[J].中国优生与遗传杂志,2017,25(6):77-79. [34] 白文学,龙川江.江津区新生儿串联质谱法遗传代谢病筛查研究[J].数理医药学杂志,2019,32(8):1180-1182. [35] Qu-ming ZHAO,Xiao-jing MA,Xiao-ling GE,et al.Pulse oximetry with clinical assessment to screen for congenitalheart disease in neonates in China:a prospective study[J].Lancet,2014,384(9945):747-754. [36] 姜晏,李璐,吴玉璘,等.出生缺陷生物样本库建设及管理实践[J].中国医药导报,2017,14(30):164-167. [37] 刘艳红,叶庆.精准医疗时代下生物样本库的建设与发展特点[J].协和医学杂志,2021,12(2):254-259. |